mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.7 |
mRNA |
QL-XI-92 |
GDSC1000 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
BRD-A71883111 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
AM-580 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
LBW242 |
CCLE |
pan-cancer |
AAC |
-0.02 |
0.7 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.7 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.7 |